Gujarat Terce Laboratories Limited

BSE:524314 Stock Report

Market Cap: ₹626.5m

Gujarat Terce Laboratories Past Earnings Performance

Past criteria checks 4/6

Gujarat Terce Laboratories's earnings have been declining at an average annual rate of -1.8%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 10.4% per year. Gujarat Terce Laboratories's return on equity is 29.6%, and it has net margins of 5.2%.

Key information

-1.8%

Earnings growth rate

11.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate10.4%
Return on equity29.6%
Net Margin5.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Gujarat Terce Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524314 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24504262050
30 Jun 24491151580
31 Mar 2448021900
31 Dec 2348752380
30 Sep 23475-22400
30 Jun 23481-112390
31 Mar 23468-171760
31 Dec 22432-412200
30 Sep 22421-372070
30 Jun 22396-261970
31 Mar 2240191820
31 Dec 2136751650
30 Sep 2133101580
30 Jun 21301-51370
31 Mar 21252-251420
31 Dec 20286-111670
30 Sep 20316-71700
30 Jun 20356101770
31 Mar 2037531870
31 Dec 19362121630
30 Sep 19344141610
30 Jun 19312-21330
31 Mar 1931041470
31 Dec 1831721500
30 Sep 1831101470
30 Jun 18313101230
31 Mar 1829031400
31 Dec 17257-31270
30 Sep 17241-31080
30 Jun 17246-71070
31 Mar 1725301200
31 Dec 16267111190
30 Sep 1627371250
30 Jun 16249-620
31 Mar 16250-71180
31 Dec 15257-161470
30 Sep 15251-121380
30 Jun 15261-91410
31 Mar 1526511190
31 Dec 1430331230
30 Sep 1430321240
30 Jun 1430141140
31 Mar 1428821220
31 Dec 131361940

Quality Earnings: 524314 has high quality earnings.

Growing Profit Margin: 524314 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524314 has become profitable over the past 5 years, growing earnings by -1.8% per year.

Accelerating Growth: 524314 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 524314 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.4%).

Return on Equity

High ROE: 524314's Return on Equity (29.6%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:30
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gujarat Terce Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution